Received Nov 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 7YS93 | — |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | UNK | 2117047 | OT |
No symptoms reported.; patient was administered Rotateq (Rotarix was administered earlier); This spontaneous report was received from a nurse and refers to a 6-month-old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant therapies were not provided. On 21-JUL-2025, also reported as at 4 months and 3 days old, the patient was vaccinated with a dose of rotavirus vaccine (ROTARIX) lot # 7YS93, expiration date 15-NOV-2026 (dose, route of administration were not provided) for prophylaxis. After administering dose, the nurse inadvertently documented the dose in the system as rotavirus vaccine (ROTATEQ). On 22-SEP-2025, also reported as at 6 months and 4 days old, the patient received a dose of rotavirus vaccine (ROTATEQ) 2 ml (reported as "2 ml/dose") orally, lot # 2117047, expiration date 18-MAY-2026 for prophylaxis in accordance with the previously documented dose, which was documented incorrectly (Interchange of vaccine products). No adverse events were reported. This is one of 3 reports received from the same reporter. Additional information is not expected.